Biotheus Inc.

Industry · 18 registered clinical trials — 7 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer CRC (Colorectal Cancer)	Phase 2	2025-08-01
Not Yet Recruiting	A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC HCC, Liver Cancer	Phase 1 / Phase 2	2024-12-01
Recruiting	PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung C SCLC	Phase 3	2024-11-13
Recruiting	PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC Triple Negative Breast Cancer(TNBC)	Phase 3	2024-06-11
Unknown	A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumou Advanced Solid Tumours	Phase 1	2023-10-30
Active Not Recruiting	A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC NSCLC	Phase 2	2023-06-26
Active Not Recruiting	A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC SCLC	Phase 2	2023-06-01
Recruiting	A Study of PM8002 in Combination With Chemotherapy in Patients With NEN Neuroendocrine Neoplasm	Phase 2	2023-05-17
Unknown	A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours Advanced Tumor	Phase 1	2022-11-21
Recruiting	A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM MPM	Phase 2	2022-08-13
Unknown	Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors Advanced Tumor	Phase 1 / Phase 2	2022-07-08
Active Not Recruiting	A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC TNBC	Phase 1 / Phase 2	2022-07-01
Active Not Recruiting	A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC SCLC	Phase 2	2022-05-27
Unknown	A Study of PM1015 in Patients With Advanced Solid Tumors Advanced Solid Tumor	Phase 1	2022-05-10
Active Not Recruiting	PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma Hepatocellular Carcinoma	Phase 2	2022-04-22
Unknown	A Study of PM1022 in Patients With Advanced Tumors Advanced Tumors	Phase 1 / Phase 2	2022-04-11
Unknown	Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors Advanced Solid Tumors	Phase 1 / Phase 2	2021-09-07
Recruiting	PM8002 in the Treatment of Patients With Advanced Solid Tumors Malignant Neoplasm	Phase 1 / Phase 2	2021-03-09